Introduction {#section1-0003319719866958}
============

Chronic limb-threatening ischemia (CLTI) is an increasing major health-care problem worldwide with a large impact on quality of life, morbidity and mortality, and health-care expenses.^[@bibr1-0003319719866958][@bibr2-0003319719866958]--[@bibr3-0003319719866958]^ The main treatment goals of CLTI management are wound healing, prevention of amputation, and preservation of ambulation.^[@bibr1-0003319719866958]^ Transcutaneous oxygen tension measurement (TcPO~2~) has been proposed as a promising noninvasive tool for the diagnosis and evaluation of CLTI, especially in diabetes.^[@bibr4-0003319719866958],[@bibr5-0003319719866958]^

The measurement of local oxygen pressure is believed to reflect the status of underlying vascularization of the skin. With the use of the so-called "Clark electrode," PO~2~ is measured by a platinum cathode and a silver anode covered with a thin membrane which is permeable for oxygen.^[@bibr6-0003319719866958]^ The electronical reduction of oxygen allows a current to flow which is proportional to the partial pressure of oxygen.^[@bibr6-0003319719866958]^ To ensure dermal permeability for oxygen, the electrode is heated creating local hyperthermia liquefying the crystalline structure of the stratum corneum. Furthermore, hyperthermia creates underlying capillary vasodilatation allowing more oxygen diffusion.^[@bibr7-0003319719866958],[@bibr8-0003319719866958]^

Despite the use of TcPO~2~ in clinical practice, its added value for the diagnosis and evaluation of therapy in patients with CLTI is strongly debated as studies have shown poor to moderate reliability and reproducibility.^[@bibr9-0003319719866958][@bibr10-0003319719866958][@bibr11-0003319719866958][@bibr12-0003319719866958]--[@bibr13-0003319719866958]^ A recent review on TcPO~2~ reported a sensitivity ranging from 0.61 to 0.82 for the prognosis of diabetic foot ulcer (DFU) healing.^[@bibr12-0003319719866958]^ Moreover, reported TcPO~2~ threshold values for the detection of ischemia or potential non-healing DFUs differ significantly.^[@bibr10-0003319719866958],[@bibr14-0003319719866958][@bibr15-0003319719866958][@bibr16-0003319719866958][@bibr17-0003319719866958][@bibr18-0003319719866958][@bibr19-0003319719866958][@bibr20-0003319719866958][@bibr21-0003319719866958][@bibr22-0003319719866958][@bibr23-0003319719866958]--[@bibr24-0003319719866958]^

Recently, the Society of Vascular Surgery proposed the "Wound, Ischemia, and foot Infection, (WIfI)" classification system to assess the risk of limb amputation and chance of successful revascularization in patients with CLTI.^[@bibr25-0003319719866958]^ Moreover, the European Society for Vascular Surgery has adopted and implemented the WIfI in their most recent guideline on the management of peripheral artery disease (PAD).^[@bibr26-0003319719866958]^ Based on the aggregate of grades determined by wound presence, level of ischemia, and severity of infection, a treatment strategy can be proposed as well as an estimation of the prognosis can be made. The WIfI recommends that if arterial calcification precludes reliable ankle--brachial index or toe pressure measurement, ischemic grade should be classified with TcPO~2~.

Since WIfI scores should ideally translate into treatment decisions, it is essential that TcPO~2~ results are reliable and reproducible. This underlines that TcPO~2~ measurement should be conducted homogenously and factors that may interfere with the test should be kept to a minimum. We assume that the discrepancies between reported threshold values in studies on TcPO~2~ are, at least partially, due to differences in protocols for measurement. Our objective is to review methods of TcPO~2~ measurement and explore potential factors that influence these values in patients with CLTI.

Methods {#section2-0003319719866958}
=======

For this review, we conducted a systematic search on PubMed, EMBASE, and the Cochrane Library for peer-reviewed publications on TcPO~2~ in patients with CLTI using synonyms for "transcutaneous --oximetry, -oxygen or TcPO~2~" and "critical limb or peripheral arterial disease and ischemia" and reviewed references of reviews. All observational studies and clinical trials on CLTI and TcPO~2~ were included. Exclusion criteria were lack of TcPO~2~ measurement, absence of CLTI, for example, DFUs without ischemia, nonhuman studies, language other than English, or if no full text was available. All eligible articles were analyzed for the protocol used to measure TcPO~2~ and---if available---the relation of TcPO~2~ values and outcomes. The following potential parameters were assessed: probe placement, probe temperature, and mentioning and/or use of a reference probe. All studies were reviewed by two researchers (B.L. and J.W.) independently.

Results {#section3-0003319719866958}
=======

A flowchart of the systematic search is shown in [Figure 1](#fig1-0003319719866958){ref-type="fig"}. A total of 437 publications were screened. After exclusion, 36 articles remained eligible for analysis. An overview of the study characteristics and results is demonstrated in [Table 1](#table1-0003319719866958){ref-type="table"}. A total of 13 studies involved an experimental intervention, 8 studies on success of percutaneous transluminal angioplasty (PTA), 7 observational studies, 6 studies on experimental diagnostics, and 2 studies on wound healing after amputation.

![Overview of study selection.](10.1177_0003319719866958-fig1){#fig1-0003319719866958}
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Overview of Included Studies.
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  Study                                                       Participants   Reference Probe           Probe Placement          Probe Temperature (°C)   Study Aim                                                                                                                               Study Type                                           Conclusion
  ----------------------------------------------------------- -------------- ------------------------- ------------------------ ------------------------ --------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Wagner et al^[@bibr27-0003319719866958]^                    34             Yes, subclavicular        Dorsum                   45                       Effect of PTA on TcPO~2~ level                                                                                                          Prospective controlled trial                         No deterioration with TcPO~2~ \>45 mm Hg (±20)
  Benhamou et al^[@bibr28-0003319719866958]^                  48             NR                        1st MT (metatarsal)      44                       Predictive value of TcPO~2~ on vascular outcome in hemodialysis population                                                              Prospective observational                            A TcPO~2~ less than 40 mm Hg at the onset of hemodialysis could identify patients at high risk of death and patients requiring vascular treatment
  Kalani et al^[@bibr14-0003319719866958]^                    50             Yes, subclavicular        1st MT                   44                       Predictive value of TcPO~2~ for ulcer healing in patients with diabetes and chronic foot ulcers                                         Prospective observational                            Probability of ulcer healing is low when TcPO~2~ is \<25 mm Hg
  Petrakis and Sciacca^[@bibr24-0003319719866958]^            60             NR                        Foot dorsum              44                       TcPO~2~ as prognostic parameter in selecting diabetic patients for permanent spinal cord device implantation                            Prospective observational                            Limb salvage in trophic lesions \<3 cm^2^ 24.2 (± 6.2) mm Hg, trophic lesions \>3 cm^2^ 20.7 (±5.3) mm Hg
  Khodabandehlou and Le Devehat^[@bibr15-0003319719866958]^   33             NR                        1st MT                   44                       Predict value of red blood cell aggregation on wound healing                                                                            Prospective observational                            94% of patients with TcPO~2~ \<10 mm Hg deteriorated, while only 53% of those with 10 \< TcPO~2~ \< 30 mm Hg, improved
  Caselli et al^[@bibr17-0003319719866958]^                   43             NR                        2nd MT                   44                       Effect of PTA on TcPO~2~ level in diabetic patients with ischemic foot ulcers                                                           Retrospective analysis                               TcPO~2~ \<20 mm Hg no limb salvage, TcPO~2~ \>35 mm Hg limb salvage
  Jacqueminet et al^[@bibr29-0003319719866958]^               32             NR                        1st MT                   44                       Effect of PTA in severe diabetic foot ischemia                                                                                          Retrospective analysis                               Partial or total healing with TcPO~2~ \> 27 ± 9 mm Hg, clinical deterioration with TcPO~2~ \< 20 ± 9 mm Hg
  De Graaff et al^[@bibr30-0003319719866958]^                 96             NR                        1st MT                   44                       Diagnostic value of TcPO~2~ in CLTI population                                                                                          Randomized controlled trial                          Use of TcPO~2~ and toe pressure measurements in management of suspected CLI does not have advantage over the clinical judgment of an experienced vascular surgeon
  Faglia et al^[@bibr31-0003319719866958]^                    564            NR                        Perilesional (dorsum)    NR                       Effectiveness of PTA in preventing major amputation in patients with CLTI                                                               Prospective observational                            In patients in whom PTA is effective in only the iliac--femoral--popliteal, or only in the peroneal axis, the change in TcPO~2~ can help to determine the probability of avoiding major amputation
  Gersbach et al^[@bibr32-0003319719866958]^                  87             NR                        1st MT                   45                       Discriminative microcirculatory screening of patients with CLTI for dorsal column stimulation                                           Prospective observational                            TcPO~2~ determinations were insufficiently reliable: 10 of 12 limbs (83%) with TcPO~2~ \>15 mm Hg were salvaged, yet also in 5 of 12 limbs with TcPO~2~ \< 15 mmHg were salvaged
  Nouvong et al^[@bibr16-0003319719866958]^                   54             NR                        Ankle                    44                       Hyperspectral imaging technology to predict healing potential of diabetic foot ulcers                                                   Prospective observational                            Nonhealing ulcer (46 ± 16 mm Hg) and healed ulcer (48 ±15 mm Hg)
  Ferraresi et al^[@bibr33-0003319719866958]^                 101            NR                        Perilesional (dorsum)    NR                       Long-term results of successful PTA for limb salvage in patients with CLTI                                                              Retrospective analysis                               NA
  De Marchi et al^[@bibr34-0003319719866958]^                 48             NR                        NR                       44                       Effect of propionyl-[l]{.smallcaps}-carnitine on microcirculation, endothelial function, and pain relief in patients affected by CLTI   Randomized controlled trial                          NA
  Ladurner et al^[@bibr22-0003319719866958]^                  141            NR                        Foot dorsum              NR                       Predict the risk of nonhealing and amputation in diabetic foot ulcer patients                                                           Prospective observational                            The overall amputation rate increased with decreasing TcPO~2~ readings (group \<20 mm Hg: 26%, group 20-40 mm Hg: 10%, group \>40 mm Hg: 5%, *P* = .014
  Uccioli et al^[@bibr10-0003319719866958]^                   510            NR                        2nd MT                   44                       Long-term outcomes of diabetic patients with CLTI                                                                                       Retrospective analysis                               Healing 46.8 ± 1.4 mmHg, nonhealing 41.8 ± 3.2 mm Hg
  Prochazka et al^[@bibr19-0003319719866958]^                 96             NR                        Perilesional             NR                       Effect of autologous bone marrow stem cells for the prevention of major amputation in patients with CLTI                                Randomized controlled trial                          NA
  Ruangsetakit et al^[@bibr20-0003319719866958]^              50             Yes, subclavicular        Dorsum                   45                       Determination threshold of transcutaneous oxygen tension (TcPO~2~) values in predicting ulcer healing in patients with CLTI             Prospective observational                            None of patients with a TcPO~2~ of \<20 mm Hg (group 1) showed signs of ulcer healing, whereas all of the patients with a TcPO~2~ of \>40 mm Hg (group 3) showed a progression toward healing during the study period
  Löndahl et al^[@bibr21-0003319719866958]^                   75             NR                        3rd MT                   42                       To evaluate circulatory variables in predicting outcome of hyperbaric oxygen therapy                                                    Randomized, double-blind, placebo controlled trial   No ulcer healed when basal TcPO~2~ was \<25 mm and all ulcers healed when TcPO~2~was \>75 mm Hg. In patients with TcPO~2~ 26-50 mm Hg and 51-75 mm Hg, healing rates were 50% and 73%, respectively
  Kim et al^[@bibr35-0003319719866958]^                       23             NR                        Perilesional (plantar)   44                       The effect of PTA on tissue oxygenation in ischemic diabetic feet                                                                       Prospective observational                            In the 28 limbs with ulcers, 25 limbs revealed marked improvements in TcPO~2~ values (\>30 mm Hg)
  Redlich et al^[@bibr23-0003319719866958]^                   28             NR                        1st MT                   NR                       Predict value of TcPO~2~ in outcome after infrageniculate PTA in diabetic patients with CLTI                                            Prospective observational                            In the nonamputation group, at 3 months after PTA, TcPO~2~ values 41.0 ± 4.5 mm Hg, from 22.8 ± 4.3 mm Hg at baseline. Amputation group was 18.9 ±6.1 mm Hg at day 9 post PTA
  Andrews et al^[@bibr36-0003319719866958]^                   307            NR                        Dorsum                   45                       Determination of TcPO~2~ cutoff points to predict wound healing or healing of partial foot amputation                                   Retrospective analysis                               10 (29%) of 34 patients with supine TcPO~2~ values lower than 20 mm Hg and uncontrolled diabetes mellitus healed within 3 months. The optimal cut point (healing or failure of healing) in the data of this study was 38 mm Hg
  Humeau-Heurtier et al^[@bibr37-0003319719866958]^           84             Yes, chest                Ankle and toe            44.5                     Feasibility of laser speckle contrast imaging in patients with CLTI                                                                     Prospective observational                            NA
  Katsui et al^[@bibr38-0003319719866958]^                    16             NR                        Ankle and 1st MT         44                       Laser speckle contrast imaging of the fluctuation in blood perfusion after local heating after PTA                                      Prospective observational                            NA
  Pardo et al^[@bibr39-0003319719866958]^                     40             NR                        Dorsum                   44                       Comparison of ankle--brachial index with TcPO~2~ in patients with CLTI prior and after PTA                                              Prospective observational                            NA
  Kavros et al^[@bibr40-0003319719866958]^                    48             NR                        Perilesional             45                       Effect of intermittent pneumatic compression in patients with CLTI                                                                      Retrospective analysis                               NA
  Klingel et al^[@bibr41-0003319719866958]^                   12             NR                        Dorsum                   44                       Effect of Rheopheresis in patients with CLTI                                                                                            Prospective pilot trial                              NA
  Kram et al^[@bibr42-0003319719866958]^                      40             Yes, arm                  Calf                     44                       Prediction of wound healing in below-knee amputation                                                                                    Prospective observational                            In patients with calf TcPO~2~ values greater than 20 mm Hg, 96% (27/28) had successful healing after below-knee amputation
  Kumagai et al^[@bibr43-0003319719866958]^                   10             NR                        NR                       43.5                     Effect of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with CLTI                              Prospective interventional                           NA
  Lenk et al^[@bibr44-0003319719866958]^                      7              NR                        NR                       43.5                     Safety of intra-arterial application of autologous circulating blood-derived progenitor cells in patients with CLTI                     Prospective intervention                             NA
  Madaric et al^[@bibr45-0003319719866958]^                   62             NR                        Forefoot                 44                       Effect of autologous bone marrow cell therapy in patients with CLTI                                                                     Prospective interventional                           Surviving patients with limb salvage at the 12-month follow-up (39/62 patients) were characterized by higher TcPO~2~ levels (16 ± 10 vs 10 ± 9 mm Hg, *P* = .01
  Malyar et al^[@bibr46-0003319719866958]^                    16             NR                        Perilesional             44.5                     Effect of autologous bone marrow cell therapy in patients with CLTI                                                                     Prospective interventional                           NA
  Melillo et al^[@bibr47-0003319719866958]^                   26             Yes, contralateral limb   NR                       45                       Effect of iloprost treatment in patients with CLTI                                                                                      Prospective interventional                           Iloprost treatment success was almost certain when TcPO~2~ was \>23 mm Hg
  Nilsson et al^[@bibr48-0003319719866958]^                   10             NR                        NR                       45                       Effects of atrinositol in patients with CLTI                                                                                            Prospective interventional                           NA
  Paraskevas et al^[@bibr49-0003319719866958]^                74             NR                        Perilesional             45                       Effect of leg elevation on TcPO~2~ measurement in patients with CLTI                                                                    Prospective observational                            NA
  Scheffler et al^[@bibr50-0003319719866958]^                 64             NR                        Forefoot                 44                       Effects of oxygen inhalation and leg elevation in patients with CLTI                                                                    Prospective observational                            In conclusion, TcPO~2~ limits of 10 and 45 mm Hg for room air breathing readings in supine and sitting position, respectively, should be applied as discriminatory values. Measurements localized outside this 2-dimensional range most probably are not associated with critical limb ischemia
  Ubbink et al^[@bibr51-0003319719866958]^                    49             NR                        Dorsum                   44                       Establishment of optimal TcPO~2~ cutoff values in patients with CLTI                                                                    Prospective observational                            The optimal TcPO~2~ cutoff value for presence of CLTI is 35 mm Hg

Abbreviations: CLTI, chronic limb-threatening ischemia; MT, metatarsal, NA, not available; NR, not reported; PTA, percutaneous transluminal angioplasty; TcPO~2~, transcutaneous oxygen tension measurement.

Probe Placement {#section4-0003319719866958}
---------------

In 24 (67%) studies, probes were placed on specific anatomical locations. These locations were on the dorsum of the foot (n = 20, 54%), ankle (n = 3, 8%) and calf (n = 1, 3%; [Table 1](#table1-0003319719866958){ref-type="table"}). A total of 7 (19%) studies placed probes adjacent to an ischemic lesion or ulcer (perilesion) irrespective of the location of the lesion. In 5 (14%) studies, the specific location was not reported ([Table 1](#table1-0003319719866958){ref-type="table"}).

Probe Temperature {#section5-0003319719866958}
-----------------

Among the selected temperature settings of the probe, the following was noted: in 18 (50%) studies, a default probe temperature of 44°C was selected, in 8 (22%) studies 45°C, in 2 (5%) studies 43.5°C, in 2 (5%) studies 44.5°C, and in 1 (3%) study 42°C. In 5 (14%) studies, probe temperature was not reported.

Reference Probe {#section6-0003319719866958}
---------------

In 31 (84%) studies, the use of a reference probe was not reported. In 4 (11%) studies, the reference probe was applied at the chest (eg, subclavicular) region, in 1 (3%) study on the arm, and in 1 (3%) on the contralateral limb. Only one study used reference probe values for the interpretation of systemic oxygenation.

Relation of TcPO~2~ and Outcome {#section7-0003319719866958}
-------------------------------

As apparent from the studies shown in [Table 1](#table1-0003319719866958){ref-type="table"}, ulcer healing and limb prognosis were in general poor if TcPO~2~ is \<20 mm Hg and were in general good if \>40 mm Hg; however, even these values varied between studies.

Discussion {#section8-0003319719866958}
==========

We found substantial differences in probe placement, probe temperature, and reference probe application in studies on TcPO~2~ use in CLTI. Moreover, cutoff values for wound healing and limb prognosis varied between studies.

It is known that the abovementioned variations in TcPO~2~ protocols affect the obtained values. For example, in general, the lower extremity has different oxygen tension levels influenced by local factors, such as skin thickness.^[@bibr52-0003319719866958]^ Hence, the selected probe site affects TcPO~2~ value. Although ischemic lesions may occur on different anatomical locations on the lower extremity,^[@bibr53-0003319719866958]^ standardization of TcPO~2~ probe location is crucial to reduce the intra- and interpatient variability.

Furthermore, TcPO~2~ measurement using the Clark electrode is influenced by the selected probe temperature.^[@bibr54-0003319719866958][@bibr55-0003319719866958][@bibr56-0003319719866958]-[@bibr57-0003319719866958]^ Cutaneous warming of, for example, the diabetic foot has shown a profound effect on TcPO~2~ values showing a 40.8 ± 23.8 mm Hg difference between a probe temperature of 37°C and 44°C.^[@bibr54-0003319719866958]^ The TcPO~2~ manuals suggest a probe temperature between 43°C and 45°C,^[@bibr58-0003319719866958]^ 44°C and 45°C,^[@bibr59-0003319719866958]^ or 45°C^[@bibr60-0003319719866958]^; hence, the majority of studies used 44°C as default temperature. However, a consensus statement of an expert panel proposed a default temperature of 45°C.^[@bibr61-0003319719866958]^ Since studies on the effect of TcPO~2~ probe temperature on TcPO~2~ values in CLTI and its relation with prognosis are lacking, the optimal probe temperature in CLTI remains unknown.

Finally, it is suggested that TcPO~2~ values are influenced by the systemic oxygen level. Therefore, the placement of a reference probe on the thorax is recommended to correct for systemic hypoxia. We found that 6 studies mentioned the use of a reference probe. However, in 2 of these studies, values or interpretation of the reference probe remained unclear. An indicator which takes into account the systemic oxygen influence is the regional perfusion index (RPI),^[@bibr62-0003319719866958],[@bibr63-0003319719866958]^ which is calculated by dividing the TcPO~2~ values of the limb by TcPO~2~ thorax values. The RPI has been successfully applied to evaluate vascularization of the extremities,^[@bibr64-0003319719866958][@bibr65-0003319719866958]-[@bibr66-0003319719866958]^ which is also recommended by TcPO~2~ measurement device manufacturers. However, thorax TcPO~2~ values are subject to the same variability as for the limb; hence, the ratio of the two could mathematically result in a greater variability than that of each factor separately. Therefore, more comparative research is required to validate and determine accurate thresholds for RPI and their added value in comparison to absolute cutoff TcPO~2~ values in CLTI for usage in clinical practice. Another proposed strategy is to add pulse oximetry (SO~2~) to rule out arterial hypoxemia.^[@bibr58-0003319719866958][@bibr59-0003319719866958]-[@bibr60-0003319719866958]^ However, studies on SO~2~ and its correlation with TcPO~2~ values of the lower limb are lacking.

A major limitation in this review is the impossibility to address the specific impact of probe location, probe temperature, and use of reference probe on the measured TcPO~2~ values due to the fundamental differences in study aim and therefore patient population in the individual studies. Moreover, the study design of the included studies was very heterogeneous: 13 studies involved an experimental intervention, 8 studies on success of PTA, 7 observational studies, 6 studies on experimental diagnostics, and 2 studies on wound healing after amputation. Still, we demonstrate that the method of TcPO~2~ use differs undoubtedly and point out the sensitivity of TcPO~2~ measurement in general. Hence, it might be suggested that heterogeneity in method of use alters TcPO~2~ values.

With the recently introduced WIfI classification system in the current ESC guidelines,^[@bibr26-0003319719866958]^ TcPO~2~ plays a role in grading ischemia and the determination of the treatment strategy in patients with CLTI. For example, if a patient has a shallow ulcer on the foot without gangrene and no signs of infection and TcPO~2~ measurement is 40 mm Hg, the patient is categorized as having a very low risk of limb amputation and low requirement for revascularization. However, if the same patient has a TcPO~2~ of 29 mm Hg, there is a moderate risk of limb amputation and a high requirement for revascularization.^[@bibr26-0003319719866958]^ This indicates a prominent role for TcPO~2~ to determine treatment strategy. Moreover, the usefulness of the ankle systolic pressure, imbedded in the WIfI classification, to predict the risk of major amputation in CLTI is currently under debate.^[@bibr67-0003319719866958]^ Especially in patients with CLTI with concomitant diabetes mellitus or chronic renal failure, TcPO~2~ seems more reliable in comparison to current macrovascular diagnostics.^[@bibr68-0003319719866958]^ Furthermore, other factors in method of TcPO~2~ use should be addressed to provide an adequate risk stratification scheme for TcPO~2~, such as positioning of the patient (supine vs sitting) and additional oxygen inhalation, both methods have proven to increase the predictive value of wound healing prognosis.^[@bibr69-0003319719866958],[@bibr70-0003319719866958]^ All these factors underline the importance of a standardized method of TcPO~2~ measurement and careful interpretation of these values. The effect of altering specific variables during TcPO~2~ assessment remains unclear. Therefore, we are currently conducting an observational study to investigate the influence of probe location and the added value of the RPI on wound healing prognosis. Also, in our vascular laboratory, we are conducting experimental TcPO~2~ studies to investigate a new photo-optical form of TcPO~2~. It has been suggested that photo-optical TcPO~2~ is not affected by probe temperature compared with the standard electrochemical TcPO~2~.

Conclusions {#section9-0003319719866958}
===========

Transcutaneous oxygen tension measurement for the evaluation of limb perfusion in patients with CLTI is applied in standard clinical practice and is included in WIfI and international guidelines on PAD management, therefore affecting treatment decisions. However, there is a strong heterogeneity in methods used to assess TcPO~2~. A substantial diversity in probe temperature, probe location, and the use of a reference probe was found among studies regarding TcPO~2~ in CLTI. The varying values and different conclusions of the reviewed studies underline the importance of a homogeneous protocol in order to interpret and possibly compare measurement values and use these values to guide treatment decisions. Prior to the implementation of TcPO~2~ as part of treatment guidelines, it is mandatory that (international) TcPO~2~ measurement protocols become available and are validated to guarantee reliable and reproducible TcPO~2~ results.
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